miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma (Q44424639)

2 December 2017

title

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma (English)

1 reference

2 December 2017

Min Deng

1

1 reference

2 December 2017

Qiurong Ye

2

1 reference

2 December 2017

Zailong Qin

3

1 reference

2 December 2017

Ying Zheng

4

1 reference

2 December 2017

Wei He

5

1 reference

2 December 2017

Hailin Tang

6

1 reference

2 December 2017

Yanhong Zhou

7

1 reference

2 December 2017

Wei Xiong

8

1 reference

2 December 2017

Ming Zhou

9

1 reference

2 December 2017

Xiaoling Li

10

1 reference

2 December 2017

Qun Yan

11

1 reference

2 December 2017

Jian Ma

12

1 reference

2 December 2017

Guiyuan Li

13

1 reference

2 December 2017

publication date

13 March 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

34

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

1793-1800

1 reference

Lactoferrin, a key molecule in immune and inflammatory processes

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Lactoferrin structure and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Lactoferrin: an alternative view of its role in human biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Growth suppression effects of recombinant adenovirus expressing human lactoferrin on cervical cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

miR-214 regulates lactoferrin expression and pro-apoptotic function in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Methylation and expression of the lactoferrin gene in human tissues and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

An analysis of human microRNA and disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0718-Y

Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice.

21 January 2018

1 reference

12 December 2020

[A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma]

1 reference

12 December 2020

Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.

1 reference

12 December 2020

Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats

1 reference

12 December 2020

A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma

1 reference

12 December 2020

A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma

1 reference

12 December 2020

[Comment for the Chinese 2008 staging system for nasopharyngeal carcinoma]

1 reference

12 December 2020

10.1007/S13277-013-0718-Y

Identifiers

DOI

1 reference

2 December 2017

1 reference